Drug Trial Radar · NCT02462083
Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Jan 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
555
Actual
Start
Aug 11, 2015
Primary completion
Jan 31, 2017
Study completion Apr 24, 2017
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Dow Pharmaceutical Sciences
- First posted
- Jun 3, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the long-term safety of IDP-118 lotion.
Conditions
- Plaque Psoriasis
Interventions
IDP-118 LotionDrug
IDP-118 lotion will be applied as per the instructions provided by the investigational center staff.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Experienced Grade 3 Local Skin ReactionsTime frame: Baseline up to Week 52
Locations
46 sites in 1 country. Site status is shown where the registry gives one.
Valeant Site 6
Mobile, Alabama
Valeant Site 24
Beverly Hills, California
Valeant Site 32
Encinitas, California
Valeant Site 27
Encino, California
Valeant Site 33
Los Angeles, California
Valeant Site 43
Los Angeles, California
Valeant Site 45
Sacramento, California
Valeant Site 25
San Diego, California
Valeant Site 4
San Diego, California
Valeant Site 44
Santa Monica, California
Valeant Site 36
Santa Rosa, California
Valeant Site 10
Englewood, Colorado
Valeant Site 3
Boynton Beach, Florida
Valeant Site 28
Coral Gables, Florida
Valeant Site 1
Miami, Florida
Valeant Site 37
North Miami Beach, Florida
Valeant Site 13
Sanford, Florida
Valeant Site 41
Snellville, Georgia
Valeant Site 17
South Bend, Indiana
Valeant Site 12
Olathe, Kansas
Valeant Site 19
Louisville, Kentucky
Valeant Site 14
Louisville, Kentucky
Valeant Site 35
Clinton Township, Michigan
Valeant Site 34
Detroit, Michigan
Valeant Site 16
Warren, Michigan
Valeant Site 18
Fridley, Minnesota
Valeant Site 31
Omaha, Nebraska
Valeant Site 2
East Windsor, New Jersey
Valeant Site 29
New York, New York
Valeant Site 39
Rochester, New York
Valeant Site 5
Portland, Oregon
Valeant Site 11
Philadelphia, Pennsylvania
Valeant Site 30
Charleston, South Carolina
Valeant Site 15
Nashville, Tennessee
Valeant Site 9
Dallas, Texas
Valeant Site 40
Houston, Texas
Valeant Site 8
Houston, Texas
Valeant Site 46
Katy, Texas
Valeant Site 20
Pflugerville, Texas
Valeant Site 21
San Antonio, Texas
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.